Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medtronic’s Letter to My Mother takes aim at heart disease among women by encouraging open conversations about heart health.

Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.